Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

AudioCodes (AUDC) Q2 Earnings Lag Estimates
AudioCodes (AUDC) Q2 Earnings Lag Estimates

AudioCodes (AUDC) came out with quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.18 per share a year ago. These figures

Lithia Motors (LAD) Beats Q2 Earnings and Revenue Estimates
Lithia Motors (LAD) Beats Q2 Earnings and Revenue Estimates

Lithia Motors (LAD) came out with quarterly earnings of $10.24 per share, beating the Zacks Consensus Estimate of $9.78 per share. This compares to earnings of $7.87 per share a year ago. These

Can Qualcomm Shock Wall Street With Its Q3 Earnings?
Can Qualcomm Shock Wall Street With Its Q3 Earnings?

Semiconductor giant Qualcomm Inc. (NASDAQ: QCOM) is set to report earnings on Wednesday, and it couldn’t come at a more pivotal moment. The stock has been in a quiet but steady uptrend since

Is Franklin Natural Resources A (FRNRX) a Strong Mutual Fund Pick Right Now?
Is Franklin Natural Resources A (FRNRX) a Strong Mutual Fund Pick Right Now?

If you have been looking for Sector - Energy funds, a place to start could be Franklin Natural Resources A (FRNRX). FRNRX has a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various

Is Baron Emerging Markets Retail (BEXFX) a Strong Mutual Fund Pick Right Now?
Is Baron Emerging Markets Retail (BEXFX) a Strong Mutual Fund Pick Right Now?

Have you been searching for a Non US - Equity fund? You might want to begin with Baron Emerging Markets Retail (BEXFX). BEXFX holds a Zacks Mutual Fund Rank of 3 (Hold), which is based on various

Is Glenmede Disciplined US Eq (GTLOX) a Strong Mutual Fund Pick Right Now?
Is Glenmede Disciplined US Eq (GTLOX) a Strong Mutual Fund Pick Right Now?

There are plenty of choices in the Large Cap Growth category, but where should you start your research? Well, one fund that may not be worth investigating is Glenmede Disciplined US Eq (GTLOX)

Is Schwab MarketTrack Growth Investor (SWHGX) a Strong Mutual Fund Pick Right Now?
Is Schwab MarketTrack Growth Investor (SWHGX) a Strong Mutual Fund Pick Right Now?

If you have been looking for Allocation Balanced funds, a place to start could be Schwab MarketTrack Growth Investor (SWHGX). SWHGX carries a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based

Is T. Rowe Price Personal Strategy Growth (TRSGX) a Strong Mutual Fund Pick Right Now?
Is T. Rowe Price Personal Strategy Growth (TRSGX) a Strong Mutual Fund Pick Right Now?

If investors are looking at the Index fund category, T. Rowe Price Personal Strategy Growth (TRSGX) could be a potential option. TRSGX carries a Zacks Mutual Fund Rank of 2 (Buy), which is based on

Nike Stock: JPMorgan Upgrade Fuels 4% Price Surge:
Nike Stock: JPMorgan Upgrade Fuels 4% Price Surge

After a prolonged downward trend since late 2021, Nike's stock showed significant signs of recovery on Monday, jumping approximately 4% and leading the Dow Jones. This impressive rally was triggered

Gold ETFs to Remain Strong Despite the Stock Market Rally
Gold ETFs to Remain Strong Despite the Stock Market Rally

Rising global trade tensions and fears over ballooning fiscal debt are driving investors toward safe-haven assets, strengthening gold’s position as a key refuge. This has led analysts in a Reuters

New Strong Buy Stocks for July 29th
New Strong Buy Stocks for July 29th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Mission Produce, Inc. AVO: This fruits producer has seen the Zacks Consensus Estimate for its current year earnings

New Strong Sell Stocks for July 29th
New Strong Sell Stocks for July 29th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Burford Capital Limited BUR is a legal finance products and services company. The Zacks Consensus Estimate for its current

Exelixis Stock: Mixed Signals After Earnings Beat
Exelixis Stock: Mixed Signals After Earnings Beat

Biotech company Exelixis delivered notably mixed second-quarter 2025 results, creating divergent investor reactions. The California-based firm reported earnings per share of $0.75, significantly

Best Growth Stocks to Buy for July 29th
Best Growth Stocks to Buy for July 29th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, July 29th:

Afya Limited AFYA:This medical education group from Brazil carries a Zacks Rank #1

Technology ETF (XLK) Hit a 52-Week High
Technology ETF (XLK) Hit a 52-Week High

For investors seeking momentum, Technology Select Sector SPDR ETF XLK is probably on the radar. The fund just hit a 52-week high and is up 52.5% from its 52-week low of $172.45 per share. 

But are

Best Value Stocks to Buy for July 29th
Best Value Stocks to Buy for July 29th

Here are three stocks with buy rank and strong value characteristics for investors to consider today, July 29th:

The Progressive Corporation PGR: This property-casualty insurance products and

Should SPDR Portfolio S&P 500 High Dividend ETF (SPYD) Be on Your Investing Radar?
Should SPDR Portfolio S&P 500 High Dividend ETF (SPYD) Be on Your Investing Radar?

Looking for broad exposure to the Large Cap Value segment of the US equity market? You should consider the SPDR Portfolio S&P 500 High Dividend ETF (SPYD), a passively managed exchange traded fund

Should Vanguard Mid-Cap Value ETF (VOE) Be on Your Investing Radar?
Should Vanguard Mid-Cap Value ETF (VOE) Be on Your Investing Radar?

Looking for broad exposure to the Mid Cap Value segment of the US equity market? You should consider the Vanguard Mid-Cap Value ETF (VOE), a passively managed exchange traded fund launched on

Should Goldman Sachs MarketBeta U.S. 1000 Equity ETF (GUSA) Be on Your Investing Radar?
Should Goldman Sachs MarketBeta U.S. 1000 Equity ETF (GUSA) Be on Your Investing Radar?

Looking for broad exposure to the Large Cap Blend segment of the US equity market? You should consider the Goldman Sachs MarketBeta U.S. 1000 Equity ETF (GUSA), a passively managed exchange traded

Should Franklin U.S. Large Cap Multifactor Index ETF (FLQL) Be on Your Investing Radar?
Should Franklin U.S. Large Cap Multifactor Index ETF (FLQL) Be on Your Investing Radar?

Designed to provide broad exposure to the Large Cap Blend segment of the US equity market, the Franklin U.S. Large Cap Multifactor Index ETF (FLQL) is a passively managed exchange traded fund

Should First Trust Dow 30 Equal Weight ETF (EDOW) Be on Your Investing Radar?
Should First Trust Dow 30 Equal Weight ETF (EDOW) Be on Your Investing Radar?

Designed to provide broad exposure to the Large Cap Blend segment of the US equity market, the First Trust Dow 30 Equal Weight ETF (EDOW) is a passively managed exchange traded fund launched on

Should You Invest in the First Trust Indxx NextG ETF (NXTG)?
Should You Invest in the First Trust Indxx NextG ETF (NXTG)?

Launched on February 17, 2011, the First Trust Indxx NextG ETF (NXTG) is a passively managed exchange traded fund designed to provide a broad exposure to the Technology - Telecom segment of the

Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?

The Inspire Corporate Bond ETF (IBD) was launched on 07/10/2017, and is a smart beta exchange traded fund designed to offer broad

Should You Invest in the iShares U.S. Infrastructure ETF (IFRA)?
Should You Invest in the iShares U.S. Infrastructure ETF (IFRA)?

Looking for broad exposure to the Utilities - Infrastructure segment of the equity market? You should consider the iShares U.S. Infrastructure ETF (IFRA), a passively managed exchange traded fund

Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the Invesco Biotechnology & Genome ETF (PBE), a passively managed exchange